Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single Percussive Ventilation Breath-hold Imaging and Delivery in Lung Tumor Stereotactic Ablative Radiation Therapy: Initial Observations From a Prospective Clinical Trial.

International journal of radiation oncology, biology, physics·2026
Same author

FLASH reduces radiation-induced oral mucositis in a mouse model of Fanconi anemia.

bioRxiv : the preprint server for biology·2026
Same author

Noninvasive Reversible Software-Based Electron FLASH Irradiation Configuration of a Linear Accelerator in Clinical Use.

International journal of radiation oncology, biology, physics·2026
Same author

Applying a portable pocket handheld ultrasound scanner to monitor tumor volume in preclinical studies.

Medical physics·2026
Same author

Addressing respiratory gating latency for accurate pulse delivery in preclinical electron FLASH irradiation on a clinical linear accelerator.

ArXiv·2026
Same author

Emerging FLASH therapy platforms for stereotactic radiosurgery and body radiotherapy.

Journal of radiosurgery and SBRT·2026

Related Experiment Video

Updated: Apr 12, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.9K

Non-Small Cell Lung Cancer, Version 6.2015.

David S Ettinger1, Douglas E Wood1, Wallace Akerley1

  • 1The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; University of Washington/Seattle Cancer Care Alliance; Huntsman Cancer Institute at the University of Utah; UC San Diego Moores Cancer Center; Fox Chase Cancer Center; University of Colorado Cancer Center; Roswell Park Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; Duke Cancer Institute; Moffitt Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; City of Hope Comprehensive Cancer Center; Vanderbilt-Ingram Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Fred & Pamela Buffett Cancer Center; Massachusetts General Hospital Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Michigan Comprehensive Cancer Center; Stanford Cancer Institute; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Mayo Clinic Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

Journal of the National Comprehensive Cancer Network : JNCCN
|May 13, 2015
PubMed
Summary
This summary is machine-generated.

Testing for specific genetic alterations like anaplastic lymphoma kinase (ALK) rearrangements and epidermal growth factor receptor (EGFR) mutations is crucial for guiding targeted therapy in advanced non-small cell lung cancer (NSCLC). These updates highlight essential testing methods for patient care.

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

543
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.9K

Related Experiment Videos

Last Updated: Apr 12, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.9K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

543
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.9K

Area of Science:

  • Oncology
  • Genetics
  • Clinical Guidelines

Background:

  • Recent advancements in non-small cell lung cancer (NSCLC) treatment emphasize targeted therapies.
  • The efficacy of targeted therapy is contingent upon the presence of specific genetic alterations in tumors.
  • The National Comprehensive Cancer Network (NCCN) provides guidelines for optimal cancer care.

Purpose of the Study:

  • To summarize recent updates to the 2015 NCCN Guidelines for NSCLC.
  • To underscore the importance of genetic testing in advanced NSCLC.
  • To describe available testing methods for actionable genetic alterations.

Main Methods:

  • Review of the 2015 NCCN Guidelines for NSCLC.
  • Identification of key genetic alterations relevant to targeted therapy.
  • Description of current diagnostic testing methodologies for these alterations.

Main Results:

  • Anaplastic lymphoma kinase (ALK) gene rearrangements and sensitizing epidermal growth factor receptor (EGFR) mutations are the most common actionable targets.
  • Testing tumor tissue is essential to identify patients eligible for targeted therapies.
  • Various testing methods are available to detect these specific genetic alterations.

Conclusions:

  • Genetic testing is a critical component of personalized medicine for advanced NSCLC.
  • Accurate and timely testing ensures appropriate patient selection for targeted treatments.
  • Adherence to updated NCCN guidelines facilitates effective management of NSCLC.